Has Charles Gordon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $204,346 in general payments to Charles Gordon, MD across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Charles Gordon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Charles Gordon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Charles Gordon, MD

Neurological Surgery · Tyler, TXNPI 1164535142

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.3%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Zimmer Biomet at 26.8% of the total. Reporting peaked in 2021 at $50,201 and has fallen 73.6% since, to $13,236 in 2025. Among neurological surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$204,346in general payments, 2019–2025

Across 60 payments — averaging $3405.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$55K
Apria Healthcare LLC$48K
Zimvie Inc.$37K
Stryker$26K
Highridge Medical LLC$23K
Osteomed LLC$6K
plus $8K from 12 others

$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Vertos Medical, Inc.$500

What the payments were for

Royalty or licence$115,11656%
Consulting fees$37,49618%
Speaking & faculty fees$48,91424%
Travel & lodging$1,5641%
Food & beverage$1,2561%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	9	$54,766
Apria Healthcare LLC	12	$48,164
Zimvie Inc.	8	$36,859
Stryker	2	$26,457
Highridge Medical LLC	6	$23,490
Osteomed LLC	1	$6,349
Vertos Medical, Inc.	2	$2,750
Nevro Corp.	2	$2,750
Orthofix Medical, Inc.	4	$1,140
Wenzel Spine, Inc.	2	$517
Painteq LLC	1	$226
The Institute Of Musculoskeletal Science And Education	1	$200
Abbott	2	$177
Medtronic	2	$150
Biotronik NRO, Inc.	1	$142
Saluda Medical Americas, Inc.	1	$117
Camber Spine Technologies LLC	3	$66
Integra Lifesciences Corporation	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ROI-A$115,116
NEURO-Other$6,349
mild Device Kit$2,750
Senza Spinal Cord Stimulation System$2,750
Lattus$1,140
primaLOK$517
PAINTEQ$226
Prospera$142
INTELLIS ADAPTIVESTIM$138
Evoke SCS$117
PROCLAIM$112

How this compares

$204,346 in reported general payments places this provider in the 90th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$108,663

Medicare patients

118

Services billed

258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$215
Gabapentin	20	$186
Methylprednisolone	12	$100
Tizanidine Hcl	18	$78

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Tyler

Koijan KainthThe Woodlands$1.3M
Luis DuarteSan Angelo$1.2M
Douglas FoxAustin$948K
Richard MeyratDallas$883K
Adam LewisCorpus Christi$792K
Arnold VardimanSan Antonio$687K
Andrew RoeserHouston$660K
Scott RobertsonRound Rock$606K
Sabatino BiancoArlington$564K
Rebecca StachniakPlano$561K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →